AmpliChip CYP450 Test
AmpliChip CYP450 Test is a diagnostic tool used in the field of pharmacogenomics to determine an individual's genetic makeup in relation to the cytochrome P450 system. This system is responsible for the metabolism of many drugs and can influence an individual's response to certain medications. The AmpliChip CYP450 Test, developed by Roche, is designed to identify variations in two specific genes, CYP2D6 and CYP2C19, which are known to influence drug metabolism.
Overview[edit | edit source]
The AmpliChip CYP450 Test is a microarray-based test that uses DNA extracted from a patient's blood sample. The test identifies specific genetic variations in the CYP2D6 and CYP2C19 genes, which are part of the cytochrome P450 system. This system is responsible for metabolizing approximately 25% of all prescription drugs, including medications for depression, cardiovascular disease, and cancer.
Procedure[edit | edit source]
The AmpliChip CYP450 Test is performed using a blood sample taken from the patient. The DNA is extracted from the blood and then applied to the AmpliChip microarray. The microarray is then scanned to identify specific genetic variations in the CYP2D6 and CYP2C19 genes.
Clinical Significance[edit | edit source]
The results of the AmpliChip CYP450 Test can provide valuable information to healthcare providers about a patient's potential response to certain medications. This can help to guide treatment decisions and potentially avoid adverse drug reactions. For example, individuals with certain genetic variations may metabolize drugs more slowly or more quickly than average, which can affect the drug's efficacy and the risk of side effects.
Limitations[edit | edit source]
While the AmpliChip CYP450 Test can provide valuable information about an individual's potential response to certain medications, it is not a substitute for clinical judgment. Healthcare providers must consider other factors, such as the patient's overall health, other medications they are taking, and their lifestyle, when making treatment decisions.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Kondreddy Naveen
